{
  "id": 1768556903578,
  "title": "Iatrogenic Glaucoma & Aqueous Misdirection Syndrome",
  "summary": "An exhaustive clinical guide to Aqueous Misdirection Syndrome (Malignant Glaucoma) and iatrogenic pressure elevations following cataract and vitreoretinal procedures. Focuses on the transition to a uni-chamber eye and managing post-operative complications.",
  "date": "2026-01-16T09:48:23.578Z",
  "data": {
    "title": "Iatrogenic Glaucoma & Aqueous Misdirection Syndrome",
    "summary": "An exhaustive clinical guide to Aqueous Misdirection Syndrome (Malignant Glaucoma) and iatrogenic pressure elevations following cataract and vitreoretinal procedures. Focuses on the transition to a uni-chamber eye and managing post-operative complications.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><circle cx='50' cy='50' r='45' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M30 50 Q50 20 70 50' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M50 50 L50 85' fill='none' stroke='red' stroke-width='2' marker-end='url(#arrow)'/><path d='M45 75 L50 85 L55 75' fill='red'/><text x='50' y='65' font-size='5' text-anchor='middle' fill='hsl(215, 90%, 45%)'>MISDIRECTION</text></svg>",
    "sections": [
      {
        "title": "Aqueous Misdirection Syndrome: Nomenclature",
        "icon": "label",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Synonyms: malignant glaucoma, ciliary block, ciliolenticular block.",
          "Classification: A form of Iatrogenic Glaucoma."
        ]
      },
      {
        "title": "The Pathological Mechanism",
        "icon": "account_tree",
        "type": "mindmap",
        "layout": "half_width",
        "color_theme": "purple",
        "content": {
          "center": "Posterior Misdirection",
          "branches": [
            "Aqueous into the vitreous",
            "Anterior displacement of vitreous",
            "Anterior displacement of ciliary processes",
            "Anterior displacement of lens/PCIOL",
            "Secondary (2°) angle closure"
          ]
        }
      },
      {
        "title": "Risk Factors",
        "icon": "warning",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": [
          "Anatomy: Short axial length, chronic angle closure, previous acute angle closure, nanophthalmos, uveal effusion syndrome.",
          "Post-procedure (Surgery): Trabeculectomy, tube procedures, cataract extraction, peripheral iridectomy.",
          "Post-procedure (Laser): Nd-yAG PI.",
          "Medication: Miotic therapy (rare)."
        ]
      },
      {
        "title": "Clinical Features Checklist",
        "icon": "visibility",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "Often dVA (due to acute i/very high IOP or significant myopic shift); may be asymptomatic.",
          "iIOP (may be normal initially).",
          "Shallow/flat AC.",
          "No pupillary block (so no iris bombé and occurs despite a patent PI).",
          "No choroidal/suprachoroidal cause (detachment/haemorrhage)."
        ]
      },
      {
        "title": "Immediate Medical Treatment",
        "icon": "medical_services",
        "type": "process",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "1. Ensure patent PI (repeat Nd-yAG PI if necessary).",
          "2. Dilate: Atropine 1% 3×/d + phenylephrine 2.5% 4×/d.",
          "3. Systemic dIOP: Acetazolamide 500mg IV stat, then 250mg PO 4×/d ± mannitol/glycerol.",
          "4. Topical dIOP: β-blocker (e.g. timolol 0.5% stat, then 2×/d) + sympathomimetic (e.g. apraclonidine 1% stat, then 3×/d)."
        ]
      },
      {
        "title": "Laser Intervention Options",
        "icon": "flare",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "yAG disruption: Disruption of anterior vitreous face (Aphakic/pseudophakic: perform posterior capsulotomy/hyaloidotomy; Phakic: attempt hyaloidotomy through patent PI).",
          "Argon laser: Apply to ciliary processes through patent PI to cause shrinkage and relieve block.",
          "Trans-scleral cyclodiode: Photocoagulation of ciliary body (one quadrant) to break acute attack (Stumpf th et al. Ophthalmology. 2008;115:2058–61)."
        ]
      },
      {
        "title": "Surgical Strategy & Goals",
        "icon": "biotech",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "blue",
        "content": "The aim in surgery is to achieve adequate posterior–anterior communication to re-establish aqueous humour flow, for which the key surgical step is peripheral zonulo-hyaloidectomy. The key is to create a uni-chamber eye."
      },
      {
        "title": "Specific Surgical Procedures",
        "icon": "precision_manufacturing",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Patient Status",
            "Procedure Components"
          ],
          "rows": [
            [
              "Phakic",
              "Cataract extraction (phacoemulsification or ECCE), posterior capsulotomy, and anterior vitrectomy. May be facilitated by preliminary pars plana vitreous debulking (VPV procedure)."
            ],
            [
              "Aphakic/Pseudophakic",
              "Pars plana vitrectomy and posterior capsulotomy."
            ]
          ]
        }
      },
      {
        "title": "Post-Cataract Surgery IOP Spikes",
        "icon": "history_edu",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Common causes: Retained viscoelastic, lens fragments, or inflammation.",
          "Prophylaxis: Single dose of acetazolamide SR 250mg.",
          "Less common causes: Suprachoroidal haemorrhage, phacolysis, phacoanaphylaxis, Amsler haemorrhage in Fuchs’ heterochromic uveitis, epithelial downgrowth, aqueous misdirection syndrome, or UGH syndrome."
        ]
      },
      {
        "title": "Post-Vitreoretinal Surgery Scenarios",
        "icon": "biotech",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Condition",
            "Mechanism / Features",
            "Treatment"
          ],
          "rows": [
            [
              "Intraocular Gases (SF6 / C3F8)",
              "Expansion or overfill of sulfur hexafluoride (SF6) or perfluoropropane (C3F8).",
              "Short-term medical (acetazolamide SR 250mg 2×/d for 5d) or remove gas."
            ],
            [
              "Scleral Buckles",
              "2° angle closure due to ciliary body swelling and choroidal detachment (vortex vein pressure).",
              "Usually resolves spontaneously; treat medically in the interim."
            ],
            [
              "Silicone Oil",
              "Oil in AC blocking trabecular meshwork; presents days to months later.",
              "Resolves spontaneously, medical tx, or cyclodestruction. Early removal (<6mo) may dIOP; later removal is less effective due to macrophage incorporation."
            ],
            [
              "Vitrectomy",
              "May facilitate ghost cell glaucoma and increase risk of rubeosis in PDR.",
              "Monitor for secondary open-angle glaucoma and rubeotic changes."
            ]
          ]
        }
      }
    ]
  },
  "chapterId": "glaucoma",
  "communityId": "sub_1768552124986_t3zlbqzsc",
  "communityAuthor": "Dodi",
  "communityDate": "2026-01-16T08:28:44.986Z",
  "_serverSynced": true,
  "_newlyImported": 1768587692880,
  "seqId": 107
}